Skip to main content
Log in

Comorbid renal tubular damage and hypoalbuminemia exacerbate cardiac prognosis in patients with chronic heart failure

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Background

Renal tubular damage (RTD) and hypoalbuminemia are risks for poor prognosis in patients with chronic heart failure (CHF). Renal tubules play a pivotal role in amino acid and albumin reabsorption, which maintain serum albumin levels. The aims of the present study were to (1) examine the association of RTD with hypoalbuminemia, and (2) assess the prognostic importance of comorbid RTD and hypoalbuminemia in patients with CHF.

Methods and results

We measured N-acetyl-β-D-glucosamidase (NAG) levels and the urinary β2-microglobulin to creatinine ratio (UBCR) in 456 patients with CHF. RTD was defined as UBCR ≥300 μg/g or NAG ≥14.2 U/g. There were moderate correlations between RTD markers and serum albumin (NAG, r = −0.428, P < 0.0001; UBCR, r = −0.399, P < 0.0001). Multivariate logistic analysis showed that RTD was significantly related to hypoalbuminemia in patients with CHF. There were 134 cardiac events during a median period of 808 days. The comorbidity of RTD and hypoalbuminemia was increased with advancing New York Heart Association functional class. Multivariate Cox proportional hazard regression analysis showed that the presence of RTD and hypoalbuminemia was associated with cardiac events. The net reclassification index was significantly improved by adding RTD and hypoalbuminemia to the basic risk factors.

Conclusion

Comorbid RTD and hypoalbuminemia are frequently observed and increase the risk for extremely poor outcome in patients with CHF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D’Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D (2002) Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106(24):3068–3072

    Article  PubMed  Google Scholar 

  2. Ohlmeier C, Mikolajczyk R, Frick J, Prutz F, Haverkamp W, Garbe E (2015) Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons. Clin Res Cardiol. doi:10.1007/s00392-015-0841-4

    PubMed  Google Scholar 

  3. Meinertz T, Diegeler A, Stiller B, Fleck E, Heinemann MK, Schmaltz AA, Vestweber M, Bestehorn K, Beckmann A, Hamm C, Cremer J (2015) German Heart Report 2013. Clin Res Cardiol 104(2):112–123. doi:10.1007/s00392-014-0799-7

    Article  PubMed  Google Scholar 

  4. Uthamalingam S, Kandala J, Daley M, Patvardhan E, Capodilupo R, Moore SA, Januzzi JL Jr (2010) Serum albumin and mortality in acutely decompensated heart failure. Am Heart J 160(6):1149–1155. doi:10.1016/j.ahj.2010.09.004

    Article  CAS  PubMed  Google Scholar 

  5. Gopal DM, Kalogeropoulos AP, Georgiopoulou VV, Tang WW, Methvin A, Smith AL, Bauer DC, Newman AB, Kim L, Harris TB, Kritchevsky SB, Butler J (2010) Serum albumin concentration and heart failure risk The Health, Aging, and Body Composition Study. Am Heart J 160(2):279–285. doi:10.1016/j.ahj.2010.05.022

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Bonilla-Palomas JL, Gamez-Lopez AL, Moreno-Conde M, Lopez-Ibanez MC, Anguita-Sanchez M, Gallego de la Sacristana A, Garcia-Catalan F, Villar-Raez A (2014) Hypoalbuminaemia in acute heart failure patients: causes and its impact on hospital and long-term mortality. J Card Fail. doi:10.1016/j.cardfail.2014.01.016

    PubMed  Google Scholar 

  7. Liu M, Chan CP, Yan BP, Zhang Q, Lam YY, Li RJ, Sanderson JE, Coats AJ, Sun JP, Yip GW, Yu CM (2012) Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 14(1):39–44. doi:10.1093/eurjhf/hfr154

    Article  CAS  PubMed  Google Scholar 

  8. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS (1995) Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 47(3):884–890

    Article  CAS  PubMed  Google Scholar 

  9. Goh CY, Vizzi G, De Cal M, Ronco C (2011) Cardiorenal syndrome: a complex series of combined heart/kidney disorders. Contrib Nephrol 174:33–45. doi:10.1159/000329233

    Article  PubMed  Google Scholar 

  10. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52(19):1527–1539. doi:10.1016/j.jacc.2008.07.051

    Article  PubMed  Google Scholar 

  11. Otaki Y, Watanabe T, Takahashi H, Narumi T, Kadowaki S, Honda Y, Arimoto T, Shishido T, Miyamoto T, Konta T, Kubota I (2014) Association of renal tubular damage with cardio-renal anemia syndrome in patients with heart failure. Int J Cardiol 173(2):222–228. doi:10.1016/j.ijcard.2014.02.044

    Article  PubMed  Google Scholar 

  12. Schmieder RE, Mitrovic V, Hengstenberg C (2015) Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin. Clin Res Cardiol. doi:10.1007/s00392-015-0839-y

    Google Scholar 

  13. Damman K, Van Veldhuisen DJ, Navis G, Vaidya VS, Smilde TD, Westenbrink BD, Bonventre JV, Voors AA, Hillege HL (2010) Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 96(16):1297–1302. doi:10.1136/hrt.2010.194878

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Otaki Y, Watanabe T, Shishido T, Takahashi H, Funayama A, Narumi T, Kadowaki S, Hasegawa H, Honda S, Netsu S, Ishino M, Arimoto T, Miyashita T, Miyamoto T, Konta T, Kubota I (2013) The impact of renal tubular damage, as assessed by urinary beta2-microglobulin-creatinine ratio, on cardiac prognosis in patients with chronic heart failure. Circ Heart Fail. doi:10.1161/circheartfailure.112.000089

    PubMed  Google Scholar 

  15. Nakhoul N, Batuman V (2011) Role of proximal tubules in the pathogenesis of kidney disease. Contrib Nephrol 169:37–50. doi:10.1159/000313944

    Article  CAS  PubMed  Google Scholar 

  16. Tojo A, Kinugasa S (2012) Mechanisms of glomerular albumin filtration and tubular reabsorption. Int J Nephrol 2012:481520. doi:10.1155/2012/481520

    PubMed Central  PubMed  Google Scholar 

  17. Tojo A (2013) The role of the kidney in protein metabolism: the capacity of tubular lysosomal proteolysis in nephrotic syndrome. Kidney Int 84(5):861–863. doi:10.1038/ki.2013.284

    Article  CAS  PubMed  Google Scholar 

  18. McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285(26):1441–1446. doi:10.1056/nejm197112232852601

    Article  CAS  PubMed  Google Scholar 

  19. Eckardt KU, Berns JS, Rocco MV, Kasiske BL (2009) Definition and classification of CKD: the debate should be about patient prognosis—a position statement from KDOQI and KDIGO. Am J Kidney Dis 53(6):915–920. doi:10.1053/j.ajkd.2009.04.001

    Article  PubMed  Google Scholar 

  20. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–266

    Google Scholar 

  21. Otaki Y, Watanabe T, Takahashi H, Hirayama A, Narumi T, Kadowaki S, Honda Y, Arimoto T, Shishido T, Miyamoto T, Konta T, Shibata Y, Fukao A, Daimon M, Ueno Y, Kato T, Kayama T, Kubota I (2014) Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study. PLoS One 9(5):e94834. doi:10.1371/journal.pone.0094834

    Article  PubMed Central  PubMed  Google Scholar 

  22. Otaki Y, Takahashi H, Watanabe T, Kadowaki S, Narumi T, Honda Y, Hasegawa H, Honda S, Funayama A, Nishiyama S, Arimoto T, Shishido T, Miyashita T, Miyamoto T, Kubota I (2014) Electrocardiographic left ventricular hypertrophy Cornell product is a feasible predictor of cardiac prognosis in patients with chronic heart failure. Clin Res Cardiol 103(4):275–284. doi:10.1007/s00392-013-0646-2

    Article  PubMed  Google Scholar 

  23. Konta T, Kudo K, Sato H, Ichikawa K, Ikeda A, Suzuki K, Hirayama A, Shibata Y, Watanabe T, Daimon M, Kato T, Ueno Y, Kayama T, Kubota I (2013) Albuminuria is an independent predictor of all-cause and cardiovascular mortality in the Japanese population: the Takahata study. Clin Exp Nephrol 17(6):805–810. doi:10.1007/s10157-013-0770-3

    Article  CAS  PubMed  Google Scholar 

  24. Valdespino-Trejo A, Orea-Tejeda A, Castillo-Martinez L, Keirns-Davis C, Montanez-Orozco A, Ortiz-Suarez G, Delgado-Perez DA, Marquez-Zepeda B (2013) Low albumin levels and high impedance ratio as risk factors for worsening kidney function during hospitalization of decompensated heart failure patients. Exp Clin Cardiol 18(2):113–117

    PubMed Central  PubMed  Google Scholar 

  25. Castillo-Martinez L, Colin-Ramirez E, Orea-Tejeda A, Gonzalez Islas DG, Rodriguez Garcia WD, Santillan Diaz C, Gutierrez Rodriguez AE, Vazquez Duran M, Keirns Davies C (2012) Cachexia assessed by bioimpedance vector analysis as a prognostic indicator in chronic stable heart failure patients. Nutrition 28(9):886–891. doi:10.1016/j.nut.2011.11.024

    Article  PubMed  Google Scholar 

  26. Arques S, Ambrosi P, Gelisse R, Luccioni R, Habib G (2003) Hypoalbuminemia in elderly patients with acute diastolic heart failure. J Am Coll Cardiol 42(4):712–716

    Article  CAS  PubMed  Google Scholar 

  27. Martinez-Santos P, Vilacosta I (2011) Cardiorenal syndrome: an unsolved clinical problem. Int J Nephrol 2011:913029. doi:10.4061/2011/913029

    PubMed Central  PubMed  Google Scholar 

  28. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW (2004) Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109(8):1004–1009. doi:10.1161/01.cir.0000116764.53225.a9

    Article  PubMed  Google Scholar 

  29. Mahon NG, Blackstone EH, Francis GS, Starling RC 3rd, Young JB, Lauer MS (2002) The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol 40(6):1106–1113

    Article  CAS  PubMed  Google Scholar 

  30. Keller C, Katz R, Sarnak MJ, Fried LF, Kestenbaum B, Cushman M, Shlipak MG (2010) Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study. Nephrol Dial Transplant 25(1):119–124. doi:10.1093/ndt/gfp429

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Kudo K, Konta T, Mashima Y, Ichikawa K, Takasaki S, Ikeda A, Hoshikawa M, Suzuki K, Shibata Y, Watanabe T, Kato T, Kawata S, Kubota I (2011) The association between renal tubular damage and rapid renal deterioration in the Japanese population: the Takahata study. Clin Exp Nephrol 15(2):235–241. doi:10.1007/s10157-010-0392-y

    Article  CAS  PubMed  Google Scholar 

  32. Nangaku M (2006) Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 17(1):17–25. doi:10.1681/asn.2005070757

    Article  CAS  PubMed  Google Scholar 

  33. Damman K, Masson S, Hillege HL, Voors AA, van Veldhuisen DJ, Rossignol P, Proietti G, Barbuzzi S, Nicolosi GL, Tavazzi L, Maggioni AP, Latini R (2013) Tubular damage and worsening renal function in chronic heart failure. JACC Heart Fail 1(5):417–424. doi:10.1016/j.jchf.2013.05.007

    Article  PubMed  Google Scholar 

  34. Shiba N, Shimokawa H (2008) Chronic heart failure in Japan: implications of the CHART studies. Vasc Health Risk Manag 4(1):103–113

    Article  PubMed Central  PubMed  Google Scholar 

  35. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H (2011) Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan—first report from the CHART-2 study. Circ J 75(4):823–833

    Article  PubMed  Google Scholar 

  36. von Scheidt W, Zugck C, Pauschinger M, Hambrecht R, Bruder O, Hartmann A, Rauchhaus M, Zahn R, Brachmann J, Tebbe U, Neumann T, Strasser RH, Bohm M, Stork S, Hochadel M, Heidemann P, Senges J (2014) Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol 103(12):1006–1014. doi:10.1007/s00392-014-0743-x

    Article  Google Scholar 

Download references

Acknowledgments

This study was supported, in part, by a grant-in-aid for Scientific Research (No. 26893025) from the Ministry of Education Culture, Sport, Science and Technology and a grant-in-aid from the global century center of excellence (COE) program of the Japan Society for the Promotion of Science.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tetsu Watanabe.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Otaki, Y., Watanabe, T., Takahashi, H. et al. Comorbid renal tubular damage and hypoalbuminemia exacerbate cardiac prognosis in patients with chronic heart failure. Clin Res Cardiol 105, 162–171 (2016). https://doi.org/10.1007/s00392-015-0899-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-015-0899-z

Keywords

Navigation